Filing metadata

Accession number
0001415889-25-018221
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Jun 25, 2025
Reporting period
Jun 23, 2025
Description
Insider transaction

Explore SEC Filings Hub